Arguments for live flavivirus vaccines
- 1 August 2004
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 364 (9433), 500
- https://doi.org/10.1016/s0140-6736(04)16802-5
Abstract
Stephen Seligman and Ernest Gould 1 Seligman SJ Gould EA Live flavivirus vaccines: reasons for caution. Lancet. 2004; 363 : 2073-2075 Summary Full Text Full Text PDF PubMed Scopus (92) Google Scholar state that the possibility of recombination between wild-type and vaccine virus strains is a drawback when using live vaccines. However, we believe that many flaviviruses identified as recombinants are artifacts created by errors in sequences deposited in public databases, and that the case for recombination has been overstated.This publication has 5 references indexed in Scilit:
- Live flavivirus vaccines: reasons for cautionThe Lancet, 2004
- Emergence and Global Spread of a Dengue Serotype 3, Subtype III VirusEmerging Infectious Diseases, 2003
- The extent of homologous recombination in members of the genus FlavivirusJournal of General Virology, 2003
- Widespread intra-serotype recombination in natural populations of dengue virusProceedings of the National Academy of Sciences of the United States of America, 1999
- Molecular evolution and epidemiology of dengue-3 virusesJournal of General Virology, 1994